ILK and lung cancer: Further studies indicate that silencing ILK through targeting small interfering RNA (siRNA) inhibits cell proliferation and growth, induces cell cycle arrest and the apoptosis of bladder (15) and pancreatic cancer cells (16), suggesting the inhibition of ILK may be a novel approach for treating lung cancer.